Read publication 

This edition covers the introduction of new price-cutting measures for pharmaceuticals and the cancellation of price regulation for medical devices, the extension of the simplified registration procedure for pharmaceuticals and medical devices procured by specialized procurement agencies, the draft procedure for publishing results of preclinical studies and clinical trials, and the recommendations of the Antimonopoly Committee of Ukraine on vertical relations in the supply and promotion of pharmaceuticals. More details on how these affect the life science and healthcare industries are provided  in the newsletter.

Explore More Insight